FACIT Expands with Expert Investment Committee to Grow its Oncology Portfolio

June 24, 2026 – FACIT’s new Investment and Asset Management Committee to provide strategic and expert advice on investment opportunities and advise on the growth and performance of FACIT’s portfolio.

Idea to Investment Podcast: How FACIT’s support propels early cancer innovations

January 17, 2025 – FACIT’s David Koehler, Director of Fund Operations, appeared on TechAlliance’s Idea to Investment podcast along with Saumik Biswas, President, CEO and Founder of Tenomix Inc. based in London, Ontario. Tenomix’s advancements exemplifies how FACIT’s continuum of commercialization programs can strategically capitalize on homegrown talent and innovations to spur promising start-ups to grow roots in Ontario and bring cancer solutions to benefit patients sooner.

Esphera SynBio closes seed financing round to advance their lead designer cancer vaccine

January 7, 2025 – FACIT congratulates portfolio company, Esphera SynBio (“Esphera”), on successfully securing seed financing and strategic partners to continue developing bespoke cancer immunotherapies using their proprietary engineered exosome-based platform for improved vaccine efficacy.